UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

Design and pre-clinical evaluation of a universal HIV-1 vaccine

PloS one, 2007-10, Vol.2 (10), p.e984-e984

2007

Volltextzugriff (PDF)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions

Scientific reports, 2023-10, Vol.13 (1), p.17155-17155, Article 17155

2023

Volltextzugriff (PDF)

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers

PloS one, 2023-10, Vol.18 (10), p.e0293148-e0293148

2023

Volltextzugriff (PDF)

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

PloS one, 2018-05, Vol.13 (5), p.e0197299

2018

Volltextzugriff (PDF)

Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

Expert review of vaccines, 2019-10, Vol.18 (10), p.1029-1041

Hanke, Tomáš

2019

Volltextzugriff (PDF)

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines

Expert opinion on biological therapy, 2014-05, Vol.14 (5), p.601-616

Hanke, Tomáš

2014

Volltextzugriff (PDF)

Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag Vaccine

Journal of Virology, 2006-05, Vol.80 (10), p.4705-4716

2006

Volltextzugriff (PDF)

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Journal of Virology, 2010-08, Vol.84 (15), p.7815-7821

2010

Volltextzugriff (PDF)

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques

European journal of immunology, 2010-07, Vol.40 (7), p.1973-1984

2010

Volltextzugriff (PDF)

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Journal of Virology, 2007-09, Vol.81 (17), p.9408-9418

2007

Volltextzugriff (PDF)

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

Nature immunology, 2017-07, Vol.18 (7), p.762

2017

Volltextzugriff (PDF)

Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques

Journal of Virology, 2010-06, Vol.84 (12), p.5898-5908

2010

Volltextzugriff (PDF)

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

Molecular therapy, 2016-04, Vol.24 (4), p.832-842

2016

Volltextzugriff (PDF)

Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1

Molecular therapy, 2014-02, Vol.22 (2), p.464-475

2014

Volltextzugriff (PDF)

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

Vaccine, 2006-01, Vol.24 (4), p.417-425

2006

Volltextzugriff (PDF)

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial

PloS one, 2014-07, Vol.9 (7), p.e101591-e101591

2014

Volltextzugriff (PDF)

Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition

Molecular therapy, 2016-02, Vol.24 (2), p.375-384

2016

Volltextzugriff (PDF)

Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine

PLoS pathogens, 2019-02, Vol.15 (2), p.e1007564

2019

Volltextzugriff (PDF)

Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy

The Journal of immunology (1950), 2007-07, Vol.179 (1), p.597-606

2007

Volltextzugriff (PDF)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens

PloS one, 2017-07, Vol.12 (7), p.e0181382-e0181382

2017

Volltextzugriff (PDF)

CD8 + T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication

Retrovirology, 2018-07, Vol.15 (1), p.46-46, Article 46

2018

Volltextzugriff (PDF)

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells

European journal of immunology, 2016-01, Vol.46 (1), p.60-69

2016

Volltextzugriff (PDF)

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens

Journal of virology, 2019-04, Vol.93 (7)

2019

Volltextzugriff (PDF)

Induction of Human Immunodeficiency Virus Type 1-Specific T Cells by a Bluetongue Virus Tubule-Vectored Vaccine Prime-Recombinant Modified Virus Ankara Boost Regimen

Journal of Virology, 2005-12, Vol.79 (23), p.14822-14833

2005

Volltextzugriff (PDF)

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Molecular therapy. Methods & clinical development, 2019-03, Vol.12, p.32-46

2019

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Englisch
(212)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(138)
Humans
(99)
Immunology
(82)
Animals
(77)
Aids Vaccines - Immunology
(75)
Hiv-1 - Immunology
(72)
Vaccines
(72)
Hiv
(71)
Human Immunodeficiency Virus
(60)
Virology
(60)
Human Immunodeficiency Virus 1
(53)
Mice
(52)
Medicine, Research & Experimental
(47)
Research & Experimental Medicine
(47)
Hiv Infections - Immunology
(42)
Cd8-Positive T-Lymphocytes - Immunology
(41)
Female
(40)
Biological And Medical Sciences
(38)
Hiv Infections - Prevention & Control
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Immunology
(21)
Vaccine
(20)
Plos One
(16)
Journal Of Virology
(14)
Journal Of General Virology
(10)
Vaccines
(9)
Molecular Therapy. Methods & Clinical Development
(8)
Aids
(7)
Frontiers In Immunology
(7)
Nature Medicine
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design and pre-clinical evaluation of a universal HIV-1 vaccine

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines

Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag Vaccine

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial

Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition

Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine

Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens

CD8 + T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens

Induction of Human Immunodeficiency Virus Type 1-Specific T Cells by a Bluetongue Virus Tubule-Vectored Vaccine Prime-Recombinant Modified Virus Ankara Boost Regimen

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Suchergebnisse filtern